Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection

Fertility and Sterility

Volumn 102, Issue 6, 2014, Pages 1650-1655.e1

  Nyborg, Kathinka Marie ^a   Kolte, Astrid Marie ^a   Larsen, Elisabeth Clare ^a   Christiansen, Ole Bjarne ^a,b  

^a Rigshospitalet   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ART; IVF ICSI; IVIg; Recurrent implantation failure; Recurrent miscarriage

Indexed keywords

IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE;

ANTICOAGULANT THERAPY; ARTICLE; BIRTH RATE; COHORT ANALYSIS; DRUG MEGADOSE; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NIDATION; PRIORITY JOURNAL; RECURRENT ABORTION; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; VEIN THROMBOSIS; ABORTION, HABITUAL; ADULT; EMBRYO TRANSFER; IMMUNOLOGY; INFERTILITY; INFERTILITY THERAPY; PREGNANCY; PROCEDURES;

ABORTION, HABITUAL; ADULT; BIRTH RATE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOMODULATION; INFERTILITY; PREDNISONE; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84921979498     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.08.029     Document Type: Article

References (42)

1. Farquhar C, Rishworth JR, Brown J, Nelen WL, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2013:CD010537.
2. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril 2012;97:1039-43.
3. Tan BK, Vandekerckhove P, Kennedy R, Keay SD. Investigation and current management of recurrent IVF treatment failure in the UK. Br J Obstet Gynecol 2005;112:773-80.
4. Caglar GS, Asimakopoulos B, Nikolettos N, Diedrich K, Al-Hasani S. Preimplantation genetic diagnosis for aneuploidy screening in repeated implantation failure. Reprod Biomed Online 2005;10:381-8.
5. Kling C, Schmutzler A, Wilke G, Hedderich J, Kabelitz D. Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions. Arch Gynecol Obstet 2008;278:135-42.
6. Barnhart K, Van Mello NM, Bourne T, Kirk E, Van Calster B, Bottomly C, et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril 2011;95:857-66.
7. Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage. BMC Med 2013;11:154.
8. Kolte AM, van Oppenraaij RH, Quenby S, Farquharson RG, Stephenson M, Goddijn M, et al. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage. Hum Reprod 2014;29:931-7.
9. Christiansen OB, Nielsen HS,Kolte AM. Future directions of failed implantation and recurrent miscarriage research. Reprod Biomed Online 2006;13:71-83.
10. Tierney JP, Welsh J, Owen P, Effective Gynaecology in Glasgow Group. Management of early pregnancy loss - a complete audit cycle. J Obstet Gynaecol 2006;26:229-32.
11. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006;21:2216-22.
12. Christiansen OB. Reproductive immunology. Mol Immunol 2013;55:8-15.
13. Ledee N, Munaut C, Aubert J, Sérazin V, Rahmati M, Chaouat G, et al. Specific and extensive endometrial deregulation is present before conception in IVF/ICSI repeated implantation failures or recurrent miscarriages. J Pathol 2011;225:554-64.
14. Coulam CB, Kaider BD, Kaider AS, Janowicz P, Roussev RG. Antiphospholipid antibodies associated with implantation failure after IVF/ET. J Assist Reprod Genet 1997;14:603-8.
15. Stern C, Chamley L, Hale L, Kloss M, Speirs A, Baker HW. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998;70:938-44.
16. Chilcott IT, Margara R, Cohen H, Rai R, Skull J, Pickering W, et al. Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril 2000;73:526-30.
17. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003;18:767-73.
18. Ledee-Bataille N, Olivennes F, Kadoch J, Dubanchet S, Frydman N, Chaouat G, et al. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of theembryo transfer. Hum Reprod 2004;19:1968-73.
19. Sacks G, Yang Y, Gowen E, Smith S, Fay L, Chapman M. Detailed analysis of peripheral blood natural killer cells in women with repeated IVF failure. Am J Reprod Immunol 2012;67:434-42.
20. Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leucocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004;64:66-9.
21. Sewell WA, Jolles S. Immunomodulatory action of intravenous immunoglobulins. Immunology 2002;107:387-93.
22. The German RSA/IVIG Group. Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group. Br J Obstet Gynaecol 1994;101:1072-7.
23. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with I.v immunoglobulin. Hum Reprod 1995;10:2690-5.
24. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333-7.
25. Perino A, Vassiliadis A, Vucetich A, Colacurci N, Menato G, Cignitti M, et al. Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study. Hum Reprod 1997;12:2388-92.
26. Stephenson MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998;39:82-8.
27. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjellberg S, Lindton B. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo controlled study. Hum Reprod 1999;14:838-41.
28. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, doubleblind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002;17:809-16.
29. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010;25:2203-9.
30. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006:CD000112.
31. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systemic review. Br J Obstet Gynecol 2007;114:134-42.
32. Ata B, Tan SL, Shehata F, Holzer H, Buckett W. A systemic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril 2011;95:1080-5.
33. Clark DA. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: methodological problems. Hum Reprod 2011;26:2586-7.
34. De Placido G, Zullo F, Cappiello F, Nazzaro A, Colacurci N, Palumbo G. Intravenous immunoglobulin (IVIG) in the prevention of implantation failures. Ann N Y Acad Sci 1994;734:232-4.
35. Sher G, Maassarani G, Zouves C, Feinman M, Sohn S, Matzner W, et al. The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 1998;39:223-5.
36. Stephenson MD, Fluker MR. Treatment of unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebocontrolled Canadian trial. Fertil Steril 2000;74:1108-13.
37. Clark DA, Coulam CB, Stricker RB. Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006;23:1-13.
38. Boomsma CM, Keay SD, Maclon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012:CD005996.
39. Virro MR, Winger EE, Reed JL. Intravenous immunoglobulin for repeated IVF failure and unexplained infertility. Am J Reprod Immunol 2012;68:218-25.
40. Heilmann L, Schorsch M, Hahn T. CD3- CD56+ CD16+ Natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment. Am J Reprod Immunol 2010;63:263-5.
41. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Elevated preconception CD56+16+ and/or Th1/Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. Am J Reprod Immunol 2011;66:394-403.
42. Heuvel Van den, Peralta CG, Hatta K, Han VK, Clark DA. Decline in number of elevated blood CD3 + CD56 + NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 2007;58:447-59.